Rapport Therapeutics Ownership | Who Owns Rapport Therapeutics?

Rapport Therapeutics Ownership Summary

Rapport Therapeutics is owned by 7.47% institutional investors, 4.68% insiders, and 87.85% retail investors. Fmr is the largest institutional shareholder, holding 1.95% of RAPP shares.

RAPP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rapport Therapeutics	7.47%	4.68%	87.85%
Sector	Healthcare Stocks	232.12%	10.72%	-142.83%
Industry	Biotech Stocks	383.51%	10.54%	-294.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	6.92M	1.95%	$205.43M
Trv gp v	7.14M	1.88%	$216.48M
Arch venture management	3.73M	1.05%	$110.74M
Cormorant asset management, lp	3.19M	0.90%	$94.82M
Capital investors	3.40M	0.90%	$103.23M
Goldman sachs group	3.00M	0.79%	$91.08M
Blackrock funding, inc. /de	2.43M	0.64%	$73.78M
Sofinnova investments	1.95M	0.55%	$57.84M
Vanguard group	1.82M	0.48%	$55.15M
Johnson & johnson	1.78M	0.47%	$54.14M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Trv gp v	7.14M	50.44%	$216.48M
Trv gp vi	969.22K	26.26%	$28.79M
Arch venture management	3.73M	22.49%	$110.74M
Johnson & johnson	1.78M	9.76%	$54.14M
Cormorant asset management, lp	3.19M	6.54%	$94.82M
Sofinnova investments	1.95M	3.16%	$57.84M
Sio capital management	185.26K	1.39%	$5.50M
Vestal point capital, lp	950.00K	1.27%	$28.21M
Siren	1.05M	1.22%	$31.29M
Sphera funds management	157.53K	0.99%	$4.68M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	6.92M	0.01%	1.44M
Baker bros. advisors lp	1.55M	0.33%	997.00K
Vestal point capital, lp	950.00K	1.27%	950.00K
Polar capital	938.95K	0.13%	938.95K
Blackrock funding, inc. /de	2.43M	0.00%	863.78K

Top Sellers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	1.10M	0.00%	-423.13K
Ubs group	226.36K	0.00%	-331.71K
Alliancebernstein	855.62K	0.01%	-299.07K
Franklin resources	-	-	-250.59K
Logos global management lp	-	-	-208.91K

New Positions

Holder	Shares	% Assets	Change	Value
Vestal point capital, lp	950.00K	1.27%	950.00K	$28.21M
Polar capital	938.95K	0.13%	938.95K	$27.89M
Adage capital partners gp	450.00K	0.02%	450.00K	$13.37M
Perceptive advisors	403.92K	0.35%	403.92K	$12.00M
Burkehill global management, lp	250.00K	0.42%	250.00K	$7.42M

Sold Out

Holder	Change
Allworth financial lp	-15.00
Clearstead advisors	-33.00
Parallel advisors	-50.00
Rise advisors	-50.00
Us bancorp \de\	-144.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	93	-29.55%	28,333,513	-42.50%	7	3.86%	62	-30.34%	16	-11.11%
Sep 30, 2025	129	69.74%	49,256,683	36.76%	13	13.46%	87	102.33%	18	12.50%
Jun 30, 2025	80	5.26%	38,487,484	29.20%	10	15.22%	45	-15.09%	18	100.00%
Mar 31, 2025	78	16.42%	38,100,888	4.65%	10	0.10%	52	36.84%	9	-30.77%
Dec 31, 2024	68	25.93%	36,575,839	28.91%	104	1.57%	39	-4.88%	13	85.71%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 18, 2026	Ceesay Abraham	Chief Executive Officer	Sell	$62.57K
Feb 18, 2026	Ceesay Abraham	Chief Executive Officer	Sell	$67.97K
Feb 18, 2026	Ceesay Abraham	Chief Executive Officer	Sell	$103.19K
Feb 18, 2026	Ceesay Abraham	Chief Executive Officer	Sell	$86.64K
Feb 17, 2026	Bredt David	Chief Scientific Officer	Sell	$25.22K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	11
2025 Q4	-	23
2025 Q3	4	10
2025 Q2	-	3
2025 Q1	3	1

RAPP Ownership FAQ

Who Owns Rapport Therapeutics?

Rapport Therapeutics shareholders are primarily institutional investors at 7.47%, followed by 4.68% insiders and 87.85% retail investors. The average institutional ownership in Rapport Therapeutics's industry, Biotech Stocks , is 383.51%, which Rapport Therapeutics falls below.

Who owns the most shares of Rapport Therapeutics?

Rapport Therapeutics’s largest shareholders are Fmr (6.92M shares, 1.95%), Trv gp v (7.14M shares, 1.88%), and Arch venture management (3.73M shares, 1.05%). Together, they hold 4.88% of Rapport Therapeutics’s total shares outstanding.

Does Blackrock own Rapport Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rapport Therapeutics.

Who is Rapport Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp v is Rapport Therapeutics’s biggest shareholder by percentage of total assets invested, with 50.44% of its assets in 7.14M Rapport Therapeutics shares, valued at 216.48M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools